Non-intoxicating cannabinoids, cannabidiol (CBD) and cannabigerol (CBG), have shown promise in treating fatty liver disease in preclinical models. The corresponding study was published in the British ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results